We are live on
!
Find out more
NM
NWI Management Portfolio holdings
AUM
$2.16B
1-Year Est. Return
62.95%
This Fund
S&P 500
This Quarter
Est. Return
+37.16%
1 Year Est. Return
+62.95%
3 Year Est. Return
+230.38%
5 Year Est. Return
+275.06%
10 Year Est. Return
+1,029.17%
AUM
$2.16B
AUM Growth
+$402M
(+23%)
Cap. Flow
-$332M
Cap. Flow
% of AUM
-15.39%
Top 10 Holdings %
Top 10 Hldgs %
64.56%
Holding
64
New
12
Increased
11
Reduced
5
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$80.3M |
| 2 |
Apple
AAPL
|
+$80.1M |
| 3 |
Meta Platforms (Facebook)
META
|
+$66M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$64.3M |
| 5 |
Revolution Medicines
RVMD
|
+$26.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$423M |
| 2 |
iShares MSCI Brazil ETF
EWZ
|
+$71.4M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$67.4M |
| 4 |
Microsoft
MSFT
|
+$56.1M |
| 5 |
Eli Lilly
LLY
|
+$55.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 33.27% |
| 2 | Technology | 21.8% |
| 3 | Healthcare | 20.41% |
| 4 | Communication Services | 9.97% |
| 5 | Financials | 8.96% |
Similar funds
OBAM
SG
MCC
MC
QOP
OIMU
VC
CGH
NWI Management's Q2 2026 Portfolio in Review
As of Q2 2026, NWI Management held 64 positions worth $2.16B, up 23% from $1.76B the previous quarter. Its ten largest holdings account for 65% of the portfolio.
NWI Management withdrew a net $332M in Q2 2026, closing 9 positions and reducing 5 holdings. Its most notable exit was Invesco QQQ Trust, an estimated $423M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 33% of assets, down from 35% a quarter earlier, followed by Technology and Healthcare.
Against the trend, NWI Management opened a new position in Revolution Medicines worth $33.7M.
- NWI Management's largest Q2 2026 buy was Revolution Medicines: 180,000 shares worth $33.7M.
- NWI Management added most to State Street Health Care Select Sector SPDR ETF in Q2 2026, an estimated $80.3M increase.
- NWI Management's biggest Q2 2026 reduction was Teva Pharmaceuticals, cutting an estimated $67.4M.
- NWI Management fully exited Invesco QQQ Trust in Q2 2026, selling an estimated $423M.
- NWI Management's ten largest holdings make up 65% of its $2.16B portfolio in Q2 2026.
- NWI Management opened 12 new positions and closed 9 in Q2 2026.
- NWI Management's portfolio value rose 23% quarter-over-quarter to $2.16B.
Based on NWI Management's 13F filing for Q2 2026, filed 14 Aug 2026.